Open AccessFertility Drugs and Young-Onset Breast Cancer: Results From the Two Sister Study
Author(s) -
Chunyuan Fei,
Lisa A. DeRoo,
Dale P. Sandler,
Clarice R. Weinberg
Publication year - 2012
Publication title -
jnci journal of the national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.797
H-Index - 356
eISSN - 1460-2105
pISSN - 0027-8874
DOI - 10.1093/jnci/djs255
Subject(s) - sister , fertility , breast cancer , medicine , oncology , cancer , gynecology , demography , environmental health , population , sociology , anthropology
Fertility drugs stimulate hyperovulation, which may have implications for breast cancer. We examined the association between use of fertility drugs (clomiphene citrate [CC] and follicle-stimulating hormone [FSH]) and subsequent risk of young-onset (<50 years at diagnosis) breast cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom